Ben Diamond, MD Profile
Ben Diamond, MD

@BenDiamondMD

Followers
801
Following
1K
Media
38
Statuses
368

Assistant Professor, Myeloma Institute @SylvesterCancer. Former @MSKCancerCenter chief fellow. Opinions expressed are my own.

Joined October 2018
Don't wanna be here? Send us removal request.
@BenDiamondMD
Ben Diamond, MD
2 years
Out in @Blood! Years of collaboration between @Sylvester @MSK @NYU. With @BachisioZic @FrancescoMaura4 @DrOlaLandgren, we reconstruct evolution of clonal hematopoiesis (CH)➡️ therapy-related myeloid neoplasm (tMN). #mmsm #leusm #chipsm (1/15).
15
23
156
@BenDiamondMD
Ben Diamond, MD
6 days
RT @DrOlaLandgren: NEW STUDY ONLINE Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific Antibodies. #mmsm ⁦@….
0
14
0
@BenDiamondMD
Ben Diamond, MD
7 days
RT @mtmdphd: Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma [May 10, 2024] @RossFireston….
0
3
0
@BenDiamondMD
Ben Diamond, MD
7 days
RT @DrKTakahashi: 🚨 New paper in @NatureGenet !.How does cancer chemotherapy reshape the HSC landscape and drive the evolution of therapy-r….
0
38
0
@BenDiamondMD
Ben Diamond, MD
25 days
RT @oncodaily: Biallelic Antigen Escape is a Mechanism of Resistance to Anti-CD38 Antibodies in MM - @FrancescoMaura4 . @BloodPortfolio @Be….
0
5
0
@BenDiamondMD
Ben Diamond, MD
25 days
RT @FrancescoMaura4: Our lab fantastic postdoc @juanjogrcs will present today our study on CTC in multiple myeloma @mmsm. Several relevant….
0
9
0
@BenDiamondMD
Ben Diamond, MD
27 days
Thanks for highlighting this work!.
@Myeloma_Doc
Robert Z. Orlowski
28 days
#Myeloma Paper of the Day: Biallelic antigen escape may be mechanism of resistance to anti-CD38 antibodies; L153H & C275Y decreased binding affinity & ADCC of daratumumab & isatuximab while a 3rd, R140G, conferred selective resistance to dara only: #mmsm
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
1
5
@BenDiamondMD
Ben Diamond, MD
28 days
Our CD38 resistance story is out in @BloodPortfolio. We had a great time putting this one together. Big multi-institutional collab!.
@FrancescoMaura4
Francesco Maura
28 days
Happy to share our new work out today on @BloodPortfolio #Blood where we report CD38 loss as recurrent mechanisms of resistance to anti-CD38 antibody in multiple myeloma. Great collaboration between @MSKCancerCenter @MSK_DeptOfMed @UCalgary @HDMyeloma @MayoClinic #mmsm #wgs.
4
3
19
@BenDiamondMD
Ben Diamond, MD
2 months
Great experience working with the team @BCD_AACR !.
@BCD_AACR
Blood Cancer Discovery
2 months
Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignancies:
Tweet media one
0
0
3
@BenDiamondMD
Ben Diamond, MD
2 months
This was a privilege to work on. Big thanks to all of our co-authors and collaborators for supporting the effort!.
@FrancescoMaura4
Francesco Maura
2 months
Excited to share our work investigating the mutagenic impact of radiotherapy in hematological cancers out today in @BCD_AACR!! 🎉 Another study born from amazing collaborations across @MoffittNews @HDMyeloma @univmiami @MSKCancerCenter @MSK_DeptOfMed 💪 #lysm #wgs #RT #mmsm
Tweet media one
1
2
16
@BenDiamondMD
Ben Diamond, MD
2 months
RT @FrancescoMaura4: Happy to share our editorial and thoughts about the AQUILA trial recently published in @NEJM. Thanks @Leif_Bergsagel f….
0
7
0
@BenDiamondMD
Ben Diamond, MD
3 months
RT @VJHemOnc: And that's a wrap on #MyelomaMRD2025! We just heard from @BenDiamondMD, David Coffey & Hans Lee (@MDAndersonNews), who highli….
0
2
0
@BenDiamondMD
Ben Diamond, MD
5 months
RT @theMMRF: Mark your calendars–our #myeloma webinar is coming up NEXT week! @myelomaDr & @BenDiamondMD will discuss the significance of v….
0
4
0
@BenDiamondMD
Ben Diamond, MD
6 months
RT @SylvesterCancer: Join us at the Lymphoma, Leukemia & Myeloma Winter Symposium! .Learn from Sylvester experts Drs. @DrOlaLandgren, @Crai….
0
6
0
@BenDiamondMD
Ben Diamond, MD
7 months
It was a privilege to work on this with all our friends and collaborators!.
@FrancescoMaura4
Francesco Maura
7 months
Just before the holidays, new preprint from the lab on @biorxivpreprint! Super talented @BenDiamondMD reports CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma #mmsm Great collaboration with @HDMyeloma @MayoClinic @univmiami @UCalgary @SanofiMyeloma 👇👇🧵 1/13
Tweet media one
1
3
15
@BenDiamondMD
Ben Diamond, MD
7 months
RT @FrancescoMaura4: Just before the holidays, new preprint from the lab on @biorxivpreprint! Super talented @BenDiamondMD reports CD38 los….
0
22
0
@BenDiamondMD
Ben Diamond, MD
7 months
RT @BrunoPaiva_UNAV: #ASH24 update: BCMA and GPRC5D are not alone anymore. CD38 gene loss may lead to antigen escape and resistance to anti….
0
16
0
@BenDiamondMD
Ben Diamond, MD
7 months
RT @NBahlis: ⁦@BenDiamondMD⁩ and ⁦@FrancescoMaura4⁩ in collaboration with Dr Pourbrahim and ⁦@hollyleeYJ⁩ presenting in CD38 mutations and….
0
13
0
@BenDiamondMD
Ben Diamond, MD
8 months
We're excited to share this work a long time in the making! It took a village. Big thanks to all of our collaborators at home and abroad! @HDMyeloma @SylvesterCancer @MoffittNews @MSKCancerCenter.
@FrancescoMaura4
Francesco Maura
8 months
Excited to share new pre-print from the lab! @BenDiamondMD investigated 580 WGS to define the mutagenic impact of radiotherapy in hematological malignancies. Great collaboration between @HDMyeloma @MoffittNews @SylvesterCancer @MSKCancerCenter 1/19
Tweet media one
2
7
30
@BenDiamondMD
Ben Diamond, MD
8 months
RT @FrancescoMaura4: Excited to share new pre-print from the lab! @BenDiamondMD investigated 580 WGS to define the mutagenic impact of radi….
0
19
0
@BenDiamondMD
Ben Diamond, MD
8 months
RT @DrOlaLandgren: Amazing science & discussion at 2nd Annual Translational & Clinical Oncology symposium today at @SylvesterCancer @univmi….
0
7
0